Generation Alpha (GNAL) 10-Q 23 Jun 20 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2020	May 31, 2020
Document And Entity Information
Entity Registrant Name	Generation Alpha, Inc.
Entity Central Index Key	0001398137
Document Type	10-Q
Document Period End Date	Mar. 31, 2020
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business Flag	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		51,274,297
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2020

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Current Assets
Cash	$ 193,000	$ 104,000
Accounts receivable, net of allowance for doubtful accounts and returns of $47,000 and $112,000, respectively	81,000
Inventories, net	303,000	390,000
Prepaid expenses and other current assets	9,000	24,000
Total Current Assets	586,000	518,000
Property and equipment, net	20,000	22,000
Right of use asset, net	428,000	427,000
Other assets	11,000	10,000
Total Assets	1,045,000	977,000
Current Liabilities
Accounts payable and accrued expenses	1,766,000	1,584,000
Legal settlements payable - past due	2,670,000	2,528,000
Leases payable, current portion	191,000	133,000
Contract obligations - past due	803,000	799,000
Notes payable to related parties - past due	790,000	790,000
Convertible notes payable to related party, net of discount of $182,000 and $178,000, respectively	1,743,000	1,597,000
Accrued interest to related parties	366,000	351,000
Loans payable	41,000	64,000
Total Current Liabilities	8,370,000	7,846,000
Leases payable, net of current portion	450,000	423,000
Derivative liabilities	2,414,000	1,332,000
Total Liabilities	11,234,000	9,601,000
Commitments and Contingencies
Shareholders' Deficit
Preferred stock, no par value, 20,000,000 shares authorized; no shares issued and outstanding at March 31, 2020 and December 31, 2019
Common stock, $0.001 par value, 100,000,000 shares authorized; 51,274,297 and 46,820,564 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively	51,000	47,000
Additional paid-in capital	31,808,000	31,739,000
Accumulated deficit	(42,048,000)	(40,410,000)
Total Shareholders' Deficit	(10,189,000)	(8,624,000)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$ 1,045,000	$ 977,000

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 47,000	$ 112,000
Convertible note payable related party discount, current	$ 182,000	$ 178,000
Preferred stock, no par value
Preferred stock, shares authorized	20,000,000	20,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	51,274,297	46,820,564
Common stock, shares outstanding	51,274,297	46,820,564

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)		3 Months Ended
		Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Sales		$ 307,000	$ 737,000
Cost of goods sold		195,000	575,000
Gross profit		112,000	162,000
Operating expenses
Selling, general and administrative expenses		361,000	1,396,000
Research and development		25,000	9,000
Impairment of right of use asset		82,000
Loss on abandonment of leasehold improvements			177,000
Amortization of license agreement			81,000
Total operating expenses		468,000	1,663,000
Loss from operations		(356,000)	(1,501,000)
Other expenses
Financing costs	[1]	(15,000)	(129,000)
Change in fair value of derivative liability		(942,000)	(98,000)
Interest expense	[2]	(325,000)	(294,000)
Total other expenses		(1,282,000)	(521,000)
Net loss		$ (1,638,000)	$ (2,022,000)
BASIC AND DILUTED LOSS PER SHARE		$ (0.03)	$ (0.04)
WEIGHTED - AVERAGE COMMON SHARES OUTSTANDING BASIC AND DILUTED		48,715,236	46,075,097
[1]	Included in financing costs are these amounts from a related party
[2]	Included in interest expense are these amounts from related parties

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Financing costs to related party	$ 15,000	$ 129,000
Interest expense to related parties	$ 207,000	$ 294,000

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Shareholders' Deficit (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2018	$ 46,000	$ 29,042,000	$ (32,516,000)	$ (3,428,000)
Balance, shares at Dec. 31, 2018	45,794,564
Fair value of common stock issued for services		187,000		187,000
Fair value of common stock issued for services, shares	452,000
Fair value of common stock issued to directors		63,000		63,000
Fair value of common stock issued to directors, shares	100,000
Fair value of vested stock options		11,000		11,000
Net loss			(2,022,000)	(2,022,000)
Balance at Mar. 31, 2019	$ 46,000	29,303,000	(34,538,000)	(5,189,000)
Balance, shares at Mar. 31, 2019	46,346,564
Balance at Dec. 31, 2019	$ 47,000	31,739,000	(40,410,000)	(8,624,000)
Balance, shares at Dec. 31, 2019	46,820,564
Fair value of common stock issued for services				177,850
Fair value of common stock issued to directors	$ 2,000	21,000		23,000
Fair value of common stock issued to directors, shares	2,166,667
Fair value of vested stock options		21,000		21,000
Common shares issued on conversion of accrued interest on note payable	$ 2,000	27,000		29,000
Common shares issued on conversion of accrued interest on note payable, shares	2,287,066
Net loss			(1,638,000)	(1,638,000)
Balance at Mar. 31, 2020	$ 51,000	$ 31,808,000	$ (42,048,000)	$ (10,189,000)
Balance, shares at Mar. 31, 2020	51,274,297

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash Flows from Operating Activities
Net loss	$ (1,638,000)	$ (2,022,000)
Adjustments to reconcile net loss to net cash used in operating activities
Provision for allowance for doubtful accounts and sales returns	(65,000)	(35,000)
Provision for inventory reserves	10,000	(74,000)
Depreciation	2,000	10,000
Amortization of right of use asset	6,000	28,000
Impairment of right of use asset	82,000
Amortization of intangible assets		81,000
Imputed interest contract obligation	4,000	4,000
Amortization on convertible notes payable	146,000	247,000
Loss on abandonment of leasehold improvements		177,000
Fair value of vested stock options	21,000	11,000
Fair value of common stock issued for services		187,000
Fair value of common stock issued to directors	23,000	63,000
Financing costs	15,000	129,000
Change in the fair value of derivative liability	942,000	98,000
(Increase) Decrease in:
Accounts receivable	(16,000)	(87,000)
Legal settlements payable	142,000
Inventories	77,000	216,000
Prepaid expenses and other	15,000	(178,000)
Other assets	(1,000)	49,000
(Decrease) Increase in:
Accounts payable and accrued expenses	182,000	673,000
Lease payable	(4,000)	(1,000)
Accrued interest to related parties	44,000	3,000
Net cash used in operating activities	(13,000)	(421,000)
Cash Flows from Investing Activities
Purchase of property and equipment		(176,000)
Net cash used in investing activities		(176,000)
Cash Flows from Financing Activities
Proceeds from convertible notes payable related party, net of fees	125,000
Payments on loans payable	(23,000)	(1,000)
Net cash (used in) provided by financing activities	102,000	(1,000)
Net increase (decrease) in cash	89,000	(598,000)
Cash beginning of period	104,000	887,000
Cash end of period	193,000	289,000
Interest paid	13,000	10,000
Taxes paid
Non-Cash Financing Activities
Recording of right to use asset and lease liability	89,000	659,000
Conversion of accrued interest to related parties for common stock	29,000
Derivative liability recorded as a valuation discount	$ 140,000

Basis of Presentation

Basis of Presentation	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	NOTE 1 – BASIS OF PRESENTATION History and Organization Generation Alpha, Inc. (the “Company”) was originally incorporated under the laws of the State of Nevada on March 2, 2007 as Cinjet, Inc. (“Cinjet”). Effective September 1, 2015, Cinjet changed its corporate name to Solis Tek Inc. (“Solis Tek”). Effective September 25, 2018, Solis Tek changed its corporate name to Generation Alpha, Inc. Effective September 25, 2018, Generation Alpha, Inc. (f/k/a Solis Tek Inc.) (the “Company”) entered into an agreement and plan of merger (the “Merger Agreement”), whereby a wholly-owned subsidiary of the Company (the “Merger Sub”) was merged into the Company (the “Merger”). Upon consummation of the Merger, the separate existence of Merger Sub ceased. On June 23, 2015, the Company entered into an Agreement of Merger and Plan of Reorganization (the “Agreement”) with Solis Tek Inc., a California corporation (“STI”), and CJA Acquisition Corp., a California corporation and a wholly owned subsidiary of the Company (“Merger Sub”), providing for the merger of Merger Sub with and into STI (the “Merger”), with STI surviving the Merger as a wholly-owned subsidiary of the Company. The Merger was accounted for as a recapitalization of the Company with STI being deemed the accounting acquirer. Overview of Business The Company is focused on the research, design, development and manufacturing of advanced, energy efficient indoor horticulture lighting, plant nutrient products, and ancillary equipment. Going Concern The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying condensed consolidated financial statements, during the three months ended March 31, 2020, the Company incurred a net loss of $1,638,000 and used cash in operations of $13,000, and had a shareholders’ deficit of $10,189,000 at March 31, 2020. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date of the financial statements being issued. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to raise additional funds and implement its business plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. In addition, the Company’s independent registered public accounting firm, in its report on the Company’s December 31, 2019 financial statements, has raised substantial doubt about the Company’s ability to continue as a going concern. At March 31, 2020, the Company had cash on hand in the amount of $193,000. Management estimates that the current funds on hand will be sufficient to continue operations through September 2020. The continuation of the Company as a going concern is dependent upon its ability to obtain necessary debt or equity financing to continue operations until it begins generating positive cash flow. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on its operations, in the case of debt financing or cause substantial dilution for the Company’s stockholders, in case of equity financing.

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries: STI; Solis Tek East, Corporation (“STE”), an entity incorporated under the laws of the State of New Jersey, Zelda Horticulture, Inc. (“Zelda”), an entity incorporated under the laws of the State of California, and YLK Partners NV, LLC (“YLK”), Generation Alpha Brands, Inc., Trilogy Dispensaries, Inc., Extracting Point, LLC (“Extracting Point”), and GrowPro Solutions, Inc., all entities formed under the laws of Nevada. Intercompany transactions and balances have been eliminated in consolidation. Loss per Share Calculations Basic earnings per share are computed by dividing net income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed by dividing the net income applicable to common stock holders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued using the treasury stock method. Potential common shares are excluded from the computation when their effect is antidilutive. The dilutive effect of potentially dilutive securities is reflected in diluted net income per share if the exercise prices were lower than the average fair market value of common shares during the reporting period. For the three months ended March 31, 2020, options to acquire 4,433,300 shares of common stock, warrants to acquire 21,283,140 shares of common stock, and 267,089,041 shares to be issued upon conversion of our convertible notes have been excluded from the calculation of weighted average common shares, as their effect would have been anti-dilutive. For the three months ended March 31, 2019, options to acquire 8,369,391 shares of common stock, warrants to acquire 12,783,140 shares of common stock, and 3,000,000 shares to be issued upon conversion of our convertible notes have been excluded from the calculation of weighted average common shares, as their effect would have been anti-dilutive. Use of Estimates The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date, and reported amounts of revenue and expenses during the reporting period. Significant estimates are used in valuing our allowances for doubtful accounts, reserves for inventory obsolescence, valuing derivative liabilities, valuing equity instruments issued for services, and valuation allowance for deferred tax assets, among others. Actual results could differ from these estimates. Segment Reporting The Company operates in one segment for the manufacture and distribution of its products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in: economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying consolidated financial statements. Revenue Recognition The Company recognizes revenue in accordance with Accounting Standard Update (“ASU”) No. 2014-09. This standard provides authoritative guidance clarifying the principles for recognizing revenue and developing a common revenue standard for U.S. generally accepted accounting principles. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in the exchange for those goods or services. Under this guidance, revenue is recognized when control of promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company reviews its sales transactions to identify contractual rights, performance obligations, and transaction prices, including the allocation of prices to separate performance obligations, if applicable. Revenue and cost of sales are recognized once products are delivered to the customer’s control and performance obligations are satisfied. All products sold by the Company are distinct individual products and consist of advanced energy efficient indoor horticulture lighting, plant nutrient products, and ancillary equipment. The products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them. Contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. The Company does not offer a general right of return on any of its sales and considers all sales as final. The Company generally provides a three-year warranty on its ballasts. However, the Company does not maintain a warranty reserve as the Company is able to chargeback its vendors for all warranty claims. As of March 31, 2020 and December 31, 2019, the Company recorded reserves for returned product in the amounts of $11,000 and $60,000, respectively, which reduced the accounts receivable balances as of those periods. In the following table, revenue is disaggregated by major product line for three months ended March 31, 2020: Sales Channels Lighting Plant Nutrients and Fertilizers Total Hydroponic resellers/retail $ 127,000 $ 175,000 $ 302,000 Direct to consumer/online 5,000 - 5,000 Total $ 132,000 $ 175,000 $ 307,000 Sales Channels Lighting Plant Nutrients and Fertilizers Total Hydroponic resellers/retail $ 590,000 $ 124,000 $ 714,000 Direct to consumer/online 23,000 - 23,000 Total $ 613,000 $ 124,000 $ 737,000 Concentration Risks The Company maintains the majority of its cash balances with one financial institution, in the form of demand deposits. Periodically, the Company had cash deposits that exceeded the federally insured limit of $250,000. The Company believes that no significant concentration of credit risk exists with respect to these cash balances because of its assessment of the creditworthiness and financial viability of the financial institution. The Company’s products require specific components that currently are available from a limited number of sources. The Company purchases some of its key products and components from single vendors. During the three months ended March 31, 2020 and 2019, its ballasts, lamps and reflectors, which comprised the clear majority of the Company’s purchases during those periods, were each only purchased from one and three separate vendors, respectively. The Company performs a regular review of customer activity and associated credit risks and does not require collateral or other arrangements. One customer accounted for 30% of the Company’s revenue for the three months ended March 31, 2020, and one customer accounted for 13% of the Company’s revenue for the three months ended March 31, 2019. There were no other customers that accounted for more than 10% of the Company’s revenue. Shipments to customers outside the United States comprised less than 5% of our sales for the three months ended March 31, 2020 and 2019, respectively. As of March 31, 2020, two customers accounted for 34% and 13% of the Company’s trade accounts receivable balance, and as of December 31, 2019, two customers accounted for 24% and 10% of the Company’s trade accounts receivable balance. Fair Value measurements The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value: ● Level 1 — Quoted prices in active markets for identical assets or liabilities. ● Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying amounts of financial instruments such as cash, accounts receivable, inventories, accounts payable and accrued liabilities, and legal settlements payable, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of notes payable approximate their fair values due to the fact that the interest rates on these obligations are based on prevailing market interest rates. The fair value of the derivative liabilities of $2,414,000 and $1,332,000 at March 31, 2020 and December 31, 2019, respectively, was valued using Level 2 inputs. Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. Recently Issued Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments. ASU 2016-13 requires entities to use a forward-looking approach based on current expected credit losses (“CECL”) to estimate credit losses on certain types of financial instruments, including trade receivables. This may result in the earlier recognition of allowances for losses. ASU 2016-13 is effective for the Company beginning January 1, 2023, and early adoption is permitted. The Company does not believe the potential impact of the new guidance and related codification improvements will be material to its financial position, results of operations and cash flows. Other recent accounting pronouncements issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

Contract Obligation Acquired fr

Contract Obligation Acquired from Related Parties	3 Months Ended
	Mar. 31, 2020
Contract Obligation Acquired From Related Parties
Contract Obligation Acquired from Related Parties	NOTE 3 – CONTRACT OBLIGATION ACQUIRED FROM RELATED PARTIES In May 2018, the Company entered into an acquisition agreement with the members, which in the aggregate, owned 100% of the membership interests in YLK, a related party. The major asset of YLK is a Cultivation Management Services Agreement (the “Management Agreement”) with an Arizona licensee that was entered into on January 5, 2018. During the year ended December 31, 2019, the Company determined the acquired assets were fully impaired, and recorded an impairment charge accordingly. The Company has a continuing obligation under the Management Agreement of $799,000 (net of discount of $51,000) as of December 31, 2019. As of March 31, 2020, the remaining Management Agreement obligation was $803,000 (net of discount of $47,000) and is reflected as a current liability in the accompanying condensed consolidated balance sheet. As of March 31, 2020, the Company is past due on its installment payments obligations under the Management Agreement.

Notes Payable to Related Partie

Notes Payable to Related Parties - Past Due	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Notes Payable to Related Parties - Past Due	NOTE 4 – NOTES PAYABLE TO RELATED PARTIES – PAST DUE Notes payable to related parties consists of the following at March 31, 2020 and December 31, 2019: March 31, 2020 December 31, 2019 Notes payable to officers/shareholders – past due (a) 600,000 600,000 Notes payable to related party – past due (b) 150,000 150,000 Notes payable to related parties – past due (c) 40,000 40,000 Total $ 790,000 $ 790,000 a. On May 9, 2016, the Company entered into note payable agreements with Alan Lien and Alvin Hao, each a former officer and director, to borrow $300,000 under each individual note. Pursuant to the terms of each of these agreements, the Company borrowed $300,000 from each of Alan Lien and Alvin Hao. The notes accrue interest at a rate of 8% per annum, are unsecured and were due on or before May 31, 2018. The loans are currently past due. A total of $600,000 was due on the combined notes at March 31, 2020 and December 31, 2019, respectively. b. On May 8, 2019, the Company entered into a note agreement with the sister of Alvin Hao, a former officer and director, to borrow $150,000. The loan accrues interest at 8% per annum (12% on default), is unsecured and was due on November 8, 2019. The note is currently past due. A total of $150,000 was due on the loan as of March 31, 2020 and December 31, 2019. c. The Company entered into note agreements with the parents of Alan Lien, the Company’s Chief Executive Officer and one of its directors. The loans accrue interest at 10% per annum, are unsecured and were due on or before December 31, 2016. The loans are currently past due. A total of $40,000 was due on the loans as of March 31, 2020 and December 31, 2019. At December 31, 2019, accrued interest on the notes payable to related parties balance was $149,000 and included in accrued interest to related parties on the condensed consolidated balance sheet. During the three months ended March 31, 2020, the Company added $18,000 of additional accrued interest, and made interest payments of $13,000, leaving an accrued interest on the notes payable to related parties balance of $154,000 at March 31, 2020.

Lease Payable

Lease Payable	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Lease Payable	NOTE 5 – LEASE PAYABLE The Company leases its executive offices and warehouse space. The Company analyzes all leases at inception to determine if a right-of-use (“ROU”) asset and lease liability should be recognized. Leases with an initial term of 12 months or less are not included on the condensed consolidated balance sheets. The lease liability is measured at the present value of future lease payments as of the lease commencement date. On March 6, 2018, the Company entered into a lease for its principal executive offices and warehouse located in Carson, California. The Company occupies a 17,640 square foot facility pursuant to a five-year lease ending on September 30, 2023, with an unaffiliated party, pursuant to which it pays $15,000 per month in rental charges. As required by ASC 842, the Company recorded a right of use asset and lease liability of $659,000 at January 1, 2019 for the net present value of future lease obligations related to the Carson property. As of December 31, 2019, balance of right of use asset amounted to $527,000 and lease liability amounted to $556,000. In January 2020, the Company vacated its office and warehouse in Carson and is currently trying to sublease the said property. The Company remains obligated under its Carson, California lease, until such time the landlord releases the Company from the lease agreement. As of the date of this report, the Company has not been released from the lease agreement, and no lease payments were made during the three months ended March 31, 2020. As of December 31, 2019, the Company recorded an impairment charge related to the of right of use asset amounting to $100,000 which reflected management’s best estimate of the cost to sublease the premises. During the period ended March 31, 2020, management revised its estimate and recorded an additional impairment charge to the right of use asset amounting to $82,000, which was charged to operating expenses in the consolidated statements of operations for the period ended March 31, 2020. On January 1, 2020, the Company relocated its principal executive offices and warehouse to 1689-A Arrow Rt., Upland, California, 91786. The Upland, California lease is for a 2,974 square foot facility pursuant to a four-year lease with an independent party ending on January 31, 2023, pursuant to which it pays $2,800 per month in rental charges. On January 1, 2020, the Company recognized an operating lease right of use asset and lease liability of $89,000, related to the Upland, California operating lease. During the three months ended March 31, 2020, the Company reflected amortization of the right of use assets of $6,000 related to its Upland, California operating lease, and recorded an impairment charge of $82,000 related to the abandoned Carson, California lease, resulting in a right of use asset balance of $428,000 as of March 31, 2020. As of December 31, 2019, liabilities recorded under operating leases were $556,000. During the three months ended March 31, 2020, the Company added $89,000 in lease liabilities related to its Upland, California operating lease, and made lease payments of $4,000 towards its operating lease liability. As of March 31, 2020, liabilities under operating leases amounted to $641,000, of which $191,000 were reflected as current due. As of March 31, 2020, the weighted average remaining lease terms for operating lease are 3.19 years, and the weighted average discount rate for operating leases is 10%. Rent expense during the three months ended March 31, 2020 and 2019 was $6,000 and $165,000 respectively.

Legal Settlements Payable - Pas

Legal Settlements Payable - Past Due	3 Months Ended
	Mar. 31, 2020
Legal Settlements Payable - Past Due
Legal Settlements Payable - Past Due	NOTE 6 – LEGAL SETTLEMENTS PAYABLE – PAST DUE As of December 31, 2019, the Company was obligated to pay $2,528,000, including accrued interest, related to legal settlements. The legal settlements obligation carries interest at rates ranging from 12% to 18%. During the three months ended March 31, 2020, $7,000 of additional settlement related expenses, and $135,000 of accrued interest were added, leaving a settlements payable balance of $2,670,000 at March 31, 2020, which was past due.

Loans Payable

Loans Payable	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Loans Payable	NOTE 7 – LOANS PAYABLE On May 21, 2019, the Company entered into a loan agreement with Celtic Bank in the principal amount of $150,000 with interest at 40.44% per annum and due on May 21, 2020. The loan was guaranteed by Alvin Hao, a former officer of the Company. A total of $64,000 was owed on the loan as of December 31, 2019. During the three months ended March 31, 2020, the Company made principal payments of $23,000, leaving a total of $41,000 owed on the loan as of March 31, 2020.

Convertible Secured Note Payabl

Convertible Secured Note Payable to Related Party	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Convertible Secured Note Payable to Related Party	NOTE 8 – CONVERTIBLE SECURED NOTE PAYABLE TO RELATED PARTY Secured note payable to related party consists of the following as of March 31, 2020 and December 31, 2019: March 31, 2020 December 31, 2019 YA II PN, Ltd. $ 1,900,000 $ 1,750,000 Less debt discount (157,000 ) (153,000 ) Secured note payable, net $ 1,743,000 $ 1,597,000 On May 10, 2018 and October 29, 2019, the Company issued convertible secured debentures (“Notes”) to YA II PN Ltd. (“YA II PN”) in the principal amounts of $1,500,000 and $275,000, respectively, with interest rates of 8% and 10%, respectively, that mature in June 2020 and April 2020, respectively. The Company is in discussion with YA II PN to extend the maturity date of the $275,000 note. The Notes provides a conversion right, in which the principal amount of the Note, together with any accrued but unpaid interest, could be converted into the Company’s common stock at a conversion price at 75% of the lowest volume weighted average price (VWAP) of the Company’s Common Stock during the 10 trading days immediately preceding the conversion date. As part of the issuance, the Company also granted YA II PN 5-year warrants, which were modified, to purchase a total of 13,000,000 shares of the Company at an exercise price of $0.05 per share, with expiration dates ranging from May 2024 to December 2024. On February 13, 2020, the Company issued a Note to YAII PN in the amount of $150,000. The Note bears interest at a rate of 10% per annum (15% on default) and has a maturity date of August 10, 2021. The Company received net proceeds of $125,000, net of closing costs of $25,000. The Note is secured by all the assets of the Company and its subsidiaries. The 2020 Note provides a conversion right, in which any portion of the principal amount of the 2020 Note, together with any accrued but unpaid interest, may be converted into the Company’s common stock at a conversion price equal to 75% of the lowest VWAP of the Company’s common stock during the ten (10) trading days immediately preceding the date of conversion, subject to adjustment. As such, the Company determined that the conversion feature created a derivative with a fair value of $140,000 at the date of issuance. The Company also granted YA II PN 5-year warrants to purchase a total of 3,000,000 shares of the Company at an exercise price of $0.05 per common share. The aggregate amount of the closing costs, and the fair value of the derivative liability, was $165,000, of which $150,000 was recorded as a valuation discount on the Note to be amortized over the life of the Note, and $15,000 was recorded as a financing cost during the three months ended March 31, 2020. The unamortized balance of the valuation discounts was $153,000 at December 31, 2019. During the three months ended March 31, 2020, valuation discounts of $150,000 were added as discussed above, and amortization of valuation discount of $146,000 was recorded as an interest cost, leaving a $157,000 remaining unamortized balance of the valuation discount at March 31, 2020. At December 31, 2019, accrued interest on the convertible secured notes payable to related parties of $202,000 was included in accrued interest to related parties on the condensed consolidated balance sheet. During the three months ended March 31, 2020, interest of $29,000 was converted into common stock (see Note 10), and the Company added $39,000 of additional accrued interest, leaving an accrued interest to related parties balance of $212,000 at March 31, 2020.

Derivative Liability

Derivative Liability	3 Months Ended
	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liability	NOTE 9 – DERIVATIVE LIABILITY The FASB has issued authoritative guidance whereby instruments which do not have fixed settlement provisions are deemed to be derivative instruments. The conversion prices and the exercise prices of the warrants described in Note 8 were not a fixed amount because they were either subject to an adjustment based on the occurrence of future offerings or events or they were variable. Since the number of shares is not explicitly limited, the Company is unable to conclude that enough authorized and unissued shares are available to settle the conversion option. In accordance with the FASB authoritative guidance, the conversion features have been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations. As of March 31, 2020 and December 31, 2019, the derivative liabilities were valued using a Black-Scholes Merton pricing model with the following assumptions: March 31, Issued During December 31, Exercise Price $ .008 $ 0.02 $ 0.05 Stock Price $ 0.01 $ 0.02 $ 0.01 Risk-free interest rate .140 % 1.46 % 1.55 – 1.60 % Expected volatility 232-280 % 232 % 201-203 % Expected life (in years) 1.0 – 1.5 1.5 0.33-0.50 Expected dividend yield 0 % 0 % 0 % Fair Value: Conversion Feature $ 2,414,000 $ 140,000 $ 1,332,000 The risk-free interest rate was based on rates established by the Federal Reserve Bank. The Company uses the historical volatility of its common stock to estimate the future volatility for its common stock. The expected life of the conversion feature of the notes was based on the remaining term of the notes. The expected dividend yield was based on the fact that the Company has not customarily paid dividends in the past and does not expect to pay dividends in the future. The balance of the derivative liability at December 31, 2019 was $1,332,000. During the three months ended March 31, 2020, the Company recognized derivative liabilities of $140,000 upon issuance of a secured convertible note (see Note 8), and recognized $942,000 as other expense, which represented the change in the fair value of the derivative from the respective prior period.

Shareholders' Equity

Shareholders' Equity	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Shareholders' Equity	NOTE 10 – SHAREHOLDERS’ EQUITY Common Shares Issued on Conversion of Convertible Note Payable During the three months ended March 31, 2020, the Company was notified by YA II PN (see Note 8) in writing of their election to convert $29,000 of interest accrued into 2,287,066 shares of the Company’s common at $0.0127 per share. Common Shares Issued to Directors The Company appointed certain directors and issued shares as part of their director compensation agreements. During the three months ended March 31, 2020, the Company issued an aggregate of 2,166,667 shares of common stock, with a fair value of $23,000 at date of grant, which was recognized as compensation cost. Summary of Stock Options A summary of stock options for the three months ended March 31, 2020, is as follows: Weighted Number Average of Exercise Options Price Balance outstanding, December 31, 2019 1,948,300 0.35 Options granted 2,500,000 0.01 Options exercised - - Options expired or forfeited (15,000 ) (0.69 ) Balance outstanding, March 31, 2020 4,433,300 $ 0.16 Balance exercisable, March 31, 2020 4,433,300 $ 0.16 On October 31, 2019, the Board of Directors of the Company reappointed Ms. Tiffany Davis as Chief Executive Officer, Chief Financial Officer and as a director, effective immediately. In connection with the appointment of Ms. Davis, Ms. Davis is entitled to receive stock options of $25,000 of shares per quarter at the then closing market price on the last trading day at the end of each calendar quarter. Accordingly, Ms. Davis was granted 2,500,000 stock options at the closing market price of $0.01 on March 31, 2020. The fair value of the 2,500,000 stock options granted was determined to be $21,000, which was recorded to stock-based compensation expense during the three months ended March 31, 2020. The fair value of options on the date of grant was estimated using the Black-Scholes option pricing model with the following weighted average assumptions: stock price of $0.03, risk-free interest rate of 1.51%, expected volatility of 155%, and an expected life of 3.0 years. Information relating to outstanding options at March 31, 2020, summarized by exercise price, is as follows: Outstanding Exercisable Weighted Weighted Average Average Exercise Price Shares Life (Years) Exercise Price Shares Exercise $ 0.01 2,500,000 5.00 $ 0.01 2,500,000 $ 0.01 $ 0.03 833,300 4.59 $ 0.03 833,300 $ 0.03 $ 0.46 100,000 3.70 $ 0.46 100,000 $ 0.46 $ 0.60 1,000,000 2.86 $ 0.60 1,000,000 $ 0.60 4,433,300 2.98 $ 0.16 4,433,300 $ 0.16 As of March 31, 2020, the Company has no outstanding unvested options with future compensation costs. In addition, there will be future compensation related to the options to be awarded to Ms. Davis under her employment agreement discussed above. The weighted-average remaining contractual life of options outstanding and exercisable at March 31, 2020 was 2.98 years. Both the outstanding and exercisable stock options had no intrinsic value at March 31, 2020. Summary of Warrants A summary of warrants for the year ended December 31, 2020, is as follows: Weighted Number Average of Exercise Warrants Price Balance outstanding, December 31, 2019 18,283,140 0.06 Warrants granted 3,000,000 0.05 Warrants exercised - - Warrants expired or forfeited - - Balance outstanding, March 31, 2020 21,283,140 $ 0.05 Balance exercisable, March 31, 2020 21,283,140 $ 0.05 Information relating to outstanding warrants at March 31, 2020, summarized by exercise price, is as follows: Outstanding Exercisable Weighted Weighted Average Average Exercise Price Per Share Shares Life (Years) Exercise Price Shares Exercise $ 0.01 5,000,000 3.11 $ 0.01 5,000,000 $ 0.01 $ 0.05 16,000,000 4.11 $ 0.05 16,000,000 $ 0.05 $ 1.10 283,140 2.56 $ 1.10 283,140 $ 1.10 21,283,140 4.08 $ 0.05 21,283,140 $ 0.05 During the three months ended March 31, 2020, the Company issued five-year warrants to purchase 3,000,000 shares of common stock at an exercise price of $0.05 as part of a secured convertible promissory note (see Note 8). The weighted-average remaining contractual life of warrants outstanding and exercisable at March 31, 2020 was 4.08 years. Both the outstanding and exercisable warrants had no intrinsic value at March 31, 2020.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	NOTE 11 – COMMITMENTS AND CONTINGENCIES Technology License Agreement The Company entered into a technology license agreement with a third-party vendor for consulting services. Under the agreement, the Company will pay the vendor a minimum consulting amount of $100,000 per year, plus a royalty of 7% of all net sales of the vendor’s products above $1,429,000 per calendar year. For the three months ended March 31, 2020 and 2019, $25,000 and $0 was recorded as research and development expense under the agreement on the condensed consolidated statements of operations related to the minimum annual fee, respectively. For each of three months ended March 31, 2020 and 2019, no royalty was recorded as cost of goods sold on the Condensed Consolidated Statements of Operations. A total of $216,000 and $191,000 was owed under the amended agreement at March 31, 2020 and December 31, 2019, respectively. Litigation On September 25, 2018, Matthew Geschke (the “Plaintiff”) filed a breach of contract case against the Company in the San Diego Superior Court of San Diego, California, under case number 37-2018-00031350-CU-OE-NC. The Plaintiff claims damages of $335,000 for breach of an employment contract when the Company terminated the Plaintiff’s employment agreement on February 22, 2018. The case is in the early discovery phase of litigation and no trial date has been set yet. The Company believes the case is without merit and intends to vigorously define this case. COVID-19 The outbreak of communicable diseases, such as a new virus known as the Coronavirus (COVID-19), could result in a widespread health crisis that could adversely affect general commercial activity and our business. An outbreak of communicable diseases in the region that the Company operates or regions from which its customers travel from or through, or the perception that such an outbreak could occur, and the measures taken by the governments of countries affected, including restricting air travel and other means of transportation, imposing quarantines and curfews and requiring the closure of the Company’s offices or other businesses, including office buildings, theatres, retail stores and other commercial venues, could adversely affect the Company’s business, financial condition or results of operations.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	NOTE 12 – SUBSEQUENT EVENTS On May 8, 2020, the Company obtained a Paycheck Protection Program loan in the amount of $205,000 pursuant to the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”). Interest on the loan is at the rate of 1% per year, and all loan payments are deferred for six months, at which time the balance is payable in 18 monthly installments if not forgiven in accordance with the CARES Act and the terms of the promissory note executed by the Company in connection with the loan. As required, the Company intends to use the Paycheck Protection Program loan proceeds for payroll, healthcare benefits, rents, and utilities. The Company will apply for forgiveness for the portion of the loan proceeds used during the next two months, as permitted under the CARES Act and the terms of the loan. Any remaining loan proceeds will continue to be used as required, for payroll, healthcare benefits, rents, and utilities to support the Company’s operations. On June 7, 2020, the Company obtained an Economic Injury Disaster Loan from the United States Small Business Administration in the amount of $150,000. Interest on the loan is at the rate of 3.75% per year, and all loan payments are deferred for twelve months, at which time the balance is payable in monthly installments of $731 over a 30 year term. The loan is secured by all of the Company’s assets.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Basis of Consolidation	Basis of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries: STI; Solis Tek East, Corporation (“STE”), an entity incorporated under the laws of the State of New Jersey, Zelda Horticulture, Inc. (“Zelda”), an entity incorporated under the laws of the State of California, and YLK Partners NV, LLC (“YLK”), Generation Alpha Brands, Inc., Trilogy Dispensaries, Inc., Extracting Point, LLC (“Extracting Point”), and GrowPro Solutions, Inc., all entities formed under the laws of Nevada. Intercompany transactions and balances have been eliminated in consolidation.
Loss Per Share Calculations	Loss per Share Calculations Basic earnings per share are computed by dividing net income (loss) available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed by dividing the net income applicable to common stock holders by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding if all dilutive potential common shares had been issued using the treasury stock method. Potential common shares are excluded from the computation when their effect is antidilutive. The dilutive effect of potentially dilutive securities is reflected in diluted net income per share if the exercise prices were lower than the average fair market value of common shares during the reporting period. For the three months ended March 31, 2020, options to acquire 4,433,300 shares of common stock, warrants to acquire 21,283,140 shares of common stock, and 267,089,041 shares to be issued upon conversion of our convertible notes have been excluded from the calculation of weighted average common shares, as their effect would have been anti-dilutive. For the three months ended March 31, 2019, options to acquire 8,369,391 shares of common stock, warrants to acquire 12,783,140 shares of common stock, and 3,000,000 shares to be issued upon conversion of our convertible notes have been excluded from the calculation of weighted average common shares, as their effect would have been anti-dilutive.
Use of Estimates	Use of Estimates The preparation of the consolidated financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date, and reported amounts of revenue and expenses during the reporting period. Significant estimates are used in valuing our allowances for doubtful accounts, reserves for inventory obsolescence, valuing derivative liabilities, valuing equity instruments issued for services, and valuation allowance for deferred tax assets, among others. Actual results could differ from these estimates.
Segment Reporting	Segment Reporting The Company operates in one segment for the manufacture and distribution of its products. In accordance with the “Segment Reporting” Topic of the ASC, the Company’s chief operating decision maker has been identified as the Chief Executive Officer and President, who reviews operating results to make decisions about allocating resources and assessing performance for the entire Company. Existing guidance, which is based on a management approach to segment reporting, establishes requirements to report selected segment information quarterly and to report annually entity-wide disclosures about products and services, major customers, and the countries in which the entity holds material assets and reports revenue. All material operating units qualify for aggregation under “Segment Reporting” due to their similar customer base and similarities in: economic characteristics; nature of products and services; and procurement, manufacturing and distribution processes. Since the Company operates in one segment, all financial information required by “Segment Reporting” can be found in the accompanying consolidated financial statements.
Revenue Recognition	Revenue Recognition The Company recognizes revenue in accordance with Accounting Standard Update (“ASU”) No. 2014-09. This standard provides authoritative guidance clarifying the principles for recognizing revenue and developing a common revenue standard for U.S. generally accepted accounting principles. The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods and services to customers in an amount that reflects the consideration to which the entity expects to be entitled in the exchange for those goods or services. Under this guidance, revenue is recognized when control of promised goods or services is transferred to the Company’s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company reviews its sales transactions to identify contractual rights, performance obligations, and transaction prices, including the allocation of prices to separate performance obligations, if applicable. Revenue and cost of sales are recognized once products are delivered to the customer’s control and performance obligations are satisfied. All products sold by the Company are distinct individual products and consist of advanced energy efficient indoor horticulture lighting, plant nutrient products, and ancillary equipment. The products are offered for sale as finished goods only, and there are no performance obligations required post-shipment for customers to derive the expected value from them. Contracts with customers contain no incentives or discounts that could cause revenue to be allocated or adjusted over time. The Company does not offer a general right of return on any of its sales and considers all sales as final. The Company generally provides a three-year warranty on its ballasts. However, the Company does not maintain a warranty reserve as the Company is able to chargeback its vendors for all warranty claims. As of March 31, 2020 and December 31, 2019, the Company recorded reserves for returned product in the amounts of $11,000 and $60,000, respectively, which reduced the accounts receivable balances as of those periods. In the following table, revenue is disaggregated by major product line for three months ended March 31, 2020: Sales Channels Lighting Plant Nutrients and Fertilizers Total Hydroponic resellers/retail $ 127,000 $ 175,000 $ 302,000 Direct to consumer/online 5,000 - 5,000 Total $ 132,000 $ 175,000 $ 307,000 Sales Channels Lighting Plant Nutrients and Fertilizers Total Hydroponic resellers/retail $ 590,000 $ 124,000 $ 714,000 Direct to consumer/online 23,000 - 23,000 Total $ 613,000 $ 124,000 $ 737,000
Concentration Risks	Concentration Risks The Company maintains the majority of its cash balances with one financial institution, in the form of demand deposits. Periodically, the Company had cash deposits that exceeded the federally insured limit of $250,000. The Company believes that no significant concentration of credit risk exists with respect to these cash balances because of its assessment of the creditworthiness and financial viability of the financial institution. The Company’s products require specific components that currently are available from a limited number of sources. The Company purchases some of its key products and components from single vendors. During the three months ended March 31, 2020 and 2019, its ballasts, lamps and reflectors, which comprised the clear majority of the Company’s purchases during those periods, were each only purchased from one and three separate vendors, respectively. The Company performs a regular review of customer activity and associated credit risks and does not require collateral or other arrangements. One customer accounted for 30% of the Company’s revenue for the three months ended March 31, 2020, and one customer accounted for 13% of the Company’s revenue for the three months ended March 31, 2019. There were no other customers that accounted for more than 10% of the Company’s revenue. Shipments to customers outside the United States comprised less than 5% of our sales for the three months ended March 31, 2020 and 2019, respectively. As of March 31, 2020, two customers accounted for 34% and 13% of the Company’s trade accounts receivable balance, and as of December 31, 2019, two customers accounted for 24% and 10% of the Company’s trade accounts receivable balance.
Fair Value Measurements	Fair Value measurements The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value: ● Level 1 — Quoted prices in active markets for identical assets or liabilities. ● Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. ● Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying amounts of financial instruments such as cash, accounts receivable, inventories, accounts payable and accrued liabilities, and legal settlements payable, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of notes payable approximate their fair values due to the fact that the interest rates on these obligations are based on prevailing market interest rates. The fair value of the derivative liabilities of $2,414,000 and $1,332,000 at March 31, 2020 and December 31, 2019, respectively, was valued using Level 2 inputs.
Derivative Financial Instruments	Derivative Financial Instruments The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13, Measurement of Credit Losses on Financial Instruments. ASU 2016-13 requires entities to use a forward-looking approach based on current expected credit losses (“CECL”) to estimate credit losses on certain types of financial instruments, including trade receivables. This may result in the earlier recognition of allowances for losses. ASU 2016-13 is effective for the Company beginning January 1, 2023, and early adoption is permitted. The Company does not believe the potential impact of the new guidance and related codification improvements will be material to its financial position, results of operations and cash flows. Other recent accounting pronouncements issued by the FASB, its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the Securities and Exchange Commission did not or are not believed by management to have a material impact on the Company’s present or future financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Schedule of Disaggregated Revenue	In the following table, revenue is disaggregated by major product line for three months ended March 31, 2020: Sales Channels Lighting Plant Nutrients and Fertilizers Total Hydroponic resellers/retail $ 127,000 $ 175,000 $ 302,000 Direct to consumer/online 5,000 - 5,000 Total $ 132,000 $ 175,000 $ 307,000 Sales Channels Lighting Plant Nutrients and Fertilizers Total Hydroponic resellers/retail $ 590,000 $ 124,000 $ 714,000 Direct to consumer/online 23,000 - 23,000 Total $ 613,000 $ 124,000 $ 737,000

Notes Payable to Related Part_2

Notes Payable to Related Parties - Past Due (Tables)	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Schedule of Notes Payable to Related Parties	Notes payable to related parties consists of the following at March 31, 2020 and December 31, 2019: March 31, 2020 December 31, 2019 Notes payable to officers/shareholders – past due (a) 600,000 600,000 Notes payable to related party – past due (b) 150,000 150,000 Notes payable to related parties – past due (c) 40,000 40,000 Total $ 790,000 $ 790,000 a. On May 9, 2016, the Company entered into note payable agreements with Alan Lien and Alvin Hao, each a former officer and director, to borrow $300,000 under each individual note. Pursuant to the terms of each of these agreements, the Company borrowed $300,000 from each of Alan Lien and Alvin Hao. The notes accrue interest at a rate of 8% per annum, are unsecured and were due on or before May 31, 2018. The loans are currently past due. A total of $600,000 was due on the combined notes at March 31, 2020 and December 31, 2019, respectively. b. On May 8, 2019, the Company entered into a note agreement with the sister of Alvin Hao, a former officer and director, to borrow $150,000. The loan accrues interest at 8% per annum (12% on default), is unsecured and was due on November 8, 2019. The note is currently past due. A total of $150,000 was due on the loan as of March 31, 2020 and December 31, 2019. c. The Company entered into note agreements with the parents of Alan Lien, the Company’s Chief Executive Officer and one of its directors. The loans accrue interest at 10% per annum, are unsecured and were due on or before December 31, 2016. The loans are currently past due. A total of $40,000 was due on the loans as of March 31, 2020 and December 31, 2019.

Convertible Secured Note Paya_2

Convertible Secured Note Payable to Related Party (Tables)	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Schedule of Secured Notes Payable to Related Party	Secured note payable to related party consists of the following as of March 31, 2020 and December 31, 2019: March 31, 2020 December 31, 2019 YA II PN, Ltd. $ 1,900,000 $ 1,750,000 Less debt discount (157,000 ) (153,000 ) Secured note payable, net $ 1,743,000 $ 1,597,000

Derivative Liability (Tables)

Derivative Liability (Tables)	3 Months Ended
	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Derivative Liability Weighted Average Assumption	As of March 31, 2020 and December 31, 2019, the derivative liabilities were valued using a Black-Scholes Merton pricing model with the following assumptions: March 31, Issued During December 31, Exercise Price $ .008 $ 0.02 $ 0.05 Stock Price $ 0.01 $ 0.02 $ 0.01 Risk-free interest rate .140 % 1.46 % 1.55 – 1.60 % Expected volatility 232-280 % 232 % 201-203 % Expected life (in years) 1.0 – 1.5 1.5 0.33-0.50 Expected dividend yield 0 % 0 % 0 % Fair Value: Conversion Feature $ 2,414,000 $ 140,000 $ 1,332,000

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Summary of Stock Options Activity	A summary of stock options for the three months ended March 31, 2020, is as follows: Weighted Number Average of Exercise Options Price Balance outstanding, December 31, 2019 1,948,300 0.35 Options granted 2,500,000 0.01 Options exercised - - Options expired or forfeited (15,000 ) (0.69 ) Balance outstanding, March 31, 2020 4,433,300 $ 0.16 Balance exercisable, March 31, 2020 4,433,300 $ 0.16
Schedule of Options Outstanding and Exercisable	Information relating to outstanding options at March 31, 2020, summarized by exercise price, is as follows: Outstanding Exercisable Weighted Weighted Average Average Exercise Price Shares Life (Years) Exercise Price Shares Exercise $ 0.01 2,500,000 5.00 $ 0.01 2,500,000 $ 0.01 $ 0.03 833,300 4.59 $ 0.03 833,300 $ 0.03 $ 0.46 100,000 3.70 $ 0.46 100,000 $ 0.46 $ 0.60 1,000,000 2.86 $ 0.60 1,000,000 $ 0.60 4,433,300 2.98 $ 0.16 4,433,300 $ 0.16
Schedule of Stock Warrants Activity	A summary of warrants for the year ended December 31, 2020, is as follows: Weighted Number Average of Exercise Warrants Price Balance outstanding, December 31, 2019 18,283,140 0.06 Warrants granted 3,000,000 0.05 Warrants exercised - - Warrants expired or forfeited - - Balance outstanding, March 31, 2020 21,283,140 $ 0.05 Balance exercisable, March 31, 2020 21,283,140 $ 0.05
Schedule of Warrants Outstanding and Exercisable	Information relating to outstanding warrants at March 31, 2020, summarized by exercise price, is as follows: Outstanding Exercisable Weighted Weighted Average Average Exercise Price Per Share Shares Life (Years) Exercise Price Shares Exercise $ 0.01 5,000,000 3.11 $ 0.01 5,000,000 $ 0.01 $ 0.05 16,000,000 4.11 $ 0.05 16,000,000 $ 0.05 $ 1.10 283,140 2.56 $ 1.10 283,140 $ 1.10 21,283,140 4.08 $ 0.05 21,283,140 $ 0.05

Basis of Presentation (Details

Basis of Presentation (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net loss	$ (1,638,000)	$ (2,022,000)
Cash in operations	(13,000)	(421,000)
Stockholders' deficit	(10,189,000)	$ (5,189,000)	$ (8,624,000)	$ (3,428,000)
Cash on hand	$ 193,000		$ 104,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Reserve of returned products	$ 11,000		$ 60,000
Federally insured limit	250,000
Fair Value, Inputs, Level 2 [Member]
Fair value of derivative liabilities	$ 2,414,000		$ 1,332,000
Outside United States [Member] | Minimum [Member]
Concentration risks percentage	5.00%	5.00%
Sales Revenue, Net [Member] | One Customer [Member]
Concentration risks percentage	30.00%	13.00%
Sales Revenue, Net [Member] | No Customer [Member]
Concentration risks percentage	10.00%
Accounts Receivable [Member] | Customer One [Member]
Concentration risks percentage	34.00%		24.00%
Accounts Receivable [Member] | Customer Two [Member]
Concentration risks percentage	13.00%		10.00%
Options [Member]
Anti-dilutive shares excluded from calculation of weighted average common shares	$ 4,433,300	$ 8,369,391
Warrants [Member]
Anti-dilutive shares excluded from calculation of weighted average common shares	21,283,140	12,783,140
Convertible Notes [Member]
Anti-dilutive shares excluded from calculation of weighted average common shares	$ 267,089,041	$ 3,000,000

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Schedule of Disaggregated Revenue (Details) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Total	$ 307,000	$ 737,000
Hydroponic Resellers/Retail [Member]
Total	302,000	714,000
Direct to Consumer/Online [Member]
Total	5,000	23,000
Lighting [Member]
Total	132,000	613,000
Lighting [Member] | Hydroponic Resellers/Retail [Member]
Total	127,000	590,000
Lighting [Member] | Direct to Consumer/Online [Member]
Total	5,000	23,000
Plant Nutrients and Fertilizers [Member]
Total	175,000	124,000
Plant Nutrients and Fertilizers [Member] | Hydroponic Resellers/Retail [Member]
Total	175,000	124,000
Plant Nutrients and Fertilizers [Member] | Direct to Consumer/Online [Member]
Total

Contract Obligation Acquired _2

Contract Obligation Acquired from Related Parties (Details Narrative) - USD ($)	Mar. 31, 2020	Dec. 31, 2019	May 31, 2018
Contract obligations - past due	$ 803,000	$ 799,000
Contract obligations net of discount	$ 47,000	$ 51,000
Acquisition Agreement [Member] | YLK Partners NV, LLC [Member]
Equity ownership percentage			100.00%

Notes Payable to Related Part_3

Notes Payable to Related Parties - Past Due (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Debt Disclosure [Abstract]
Accrued interest on notes payable to related parties	$ 154,000	$ 149,000
Additional accrued interest	18,000
Interest payments	$ 13,000

Notes Payable to Related Part_4

Notes Payable to Related Parties - Past Due - Schedule of Notes Payable to Related Parties (Details) - USD ($)		Mar. 31, 2020	Dec. 31, 2019
Note payable, net		$ 790,000	$ 790,000
Notes Payable to Officers/Shareholders - Past Due [Member]
Note payable, net	[1]	600,000	600,000
Notes Payable to Related Party - Past Due [Member]
Note payable, net	[2]	150,000	150,000
Notes Payable to Related Parties - Past Due [Member]
Note payable, net	[3]	$ 40,000	$ 40,000
[1]	On May 9, 2016, the Company entered into note payable agreements with Alan Lien and Alvin Hao, each a former officer and director, to borrow $300,000 under each individual note. Pursuant to the terms of each of these agreements, the Company borrowed $300,000 from each of Alan Lien and Alvin Hao. The notes accrue interest at a rate of 8% per annum, are unsecured and were due on or before May 31, 2018. The loans are currently past due. A total of $600,000 was due on the combined notes at March 31, 2020 and December 31, 2019, respectively.
[2]	On May 8, 2019, the Company entered into a note agreement with the sister of Alvin Hao, a former officer and director, to borrow $150,000. The loan accrues interest at 8% per annum (12% on default), is unsecured and was due on November 8, 2019. The note is currently past due. A total of $150,000 was due on the loan as of March 31, 2020 and December 31, 2019.
[3]	The Company entered into note agreements with the parents of Alan Lien, the Company's Chief Executive Officer and one of its directors. The loans accrue interest at 10% per annum, are unsecured and were due on or before December 31, 2016. The loans are currently past due. A total of $40,000 was due on the loans as of March 31, 2020 and December 31, 2019.

Notes Payable to Related Part_5

Notes Payable to Related Parties - Past Due - Schedule of Notes Payable to Related Parties (Details) (Parenthetical) - USD ($)	May 08, 2019	May 09, 2016	Mar. 31, 2020	Dec. 31, 2019
Note payable - related parties			$ 790,000	$ 790,000
Notes Payable Agreement [Member] | Mr. Alan Lien [Member]
Purchases from related party		$ 300,000
Debt instruments maturity		May 31, 2018
Notes Payable Agreement [Member] | Mr. Alan Lien [Member]
Interest rate on notes		8.00%
Notes Payable Agreement [Member] | Mr. Alvin Hao [Member]
Purchases from related party		$ 300,000
Debt instruments maturity		May 31, 2018
Notes Payable Agreement [Member] | Mr. Hao [Member]
Interest rate on notes		8.00%
Notes Payable Agreement [Member] | Mr. Alan Lien and Mr. Alvin Hao [Member]
Note payable - related parties			600,000	600,000
Notes Payable Agreement [Member] | Sister of Alvin Hao [Member]
Purchases from related party	$ 150,000
Interest rate on notes	8.00%
Debt instruments maturity	Nov. 8, 2019
Note payable - related parties			$ 150,000	150,000
Default interest rate	12.00%
Note Agreements [Member] | Mr. Alan Lien [Member]
Interest rate on notes			10.00%
Debt instruments maturity			Dec. 31, 2016
Note payable - related parties			$ 40,000	$ 40,000

Lease Payable (Details Narrativ

Lease Payable (Details Narrative)	Jan. 02, 2019USD ($)	Mar. 06, 2018USD ($)ft²	Mar. 31, 2020USD ($)ft²	Mar. 31, 2019USD ($)	Dec. 31, 2019USD ($)	Jan. 02, 2020USD ($)
Rental charges			$ 6,000	$ 165,000
Right of use asset and lease liability	$ 659,000
Right of use asset			428,000		$ 427,000
Lease liability			641,000		556,000
Lease payment
Cost of sublease					$ 100,000
Impairment charge of right of use asset			$ 82,000
Lease agreement remaining lease terms			3 years 2 months 8 days
Weighted average discount rate for operating leases			10.00%
Current Due [Member]
Lease liability			$ 191,000
California Lease [Member]
Lease initial term			4 years
Area of land | ft²			2,974
Rental charges			$ 2,800
Right of use asset						$ 89,000
Lease liability			89,000			$ 89,000
Lease payment			4,000
Impairment charge of right of use asset			$ 82,000
Lease expiration date			Jan. 31, 2023
Amortization of right of use assets			$ 6,000
Independent [Member]
Lease initial term		5 years
Area of land | ft²		17,640
Rental charges		$ 15,000
Lease Agreement [Member]
Lease initial term		12 months

Legal Settlements Payable - P_2

Legal Settlements Payable - Past Due (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Payments for legal settlements	$ 2,670,000	$ 2,528,000
Additional settlement related expenses	7,000
Litigation settlement accrued interest	$ 135,000
Minimum [Member]
Litigation settlement interest rate	12.00%
Maximum [Member]
Litigation settlement interest rate	18.00%

Loans Payable (Details Narrativ

Loans Payable (Details Narrative) - USD ($)	May 21, 2019	Mar. 31, 2020	Dec. 31, 2019
Loans payable		$ 41,000	$ 64,000
Principal payments of loan		$ 23,000
Loan Agreement [Member] | Celtic Bank [Member]
Principal amount	$ 150,000
Interest rate	40.44%
Debt maturity date	May 21, 2020

Convertible Secured Note Paya_3

Convertible Secured Note Payable to Related Party (Details Narrative)	Feb. 13, 2020USD ($)Integer$ / sharesshares	Oct. 29, 2019USD ($)Integer$ / sharesshares	May 10, 2018USD ($)Integer$ / sharesshares	Mar. 31, 2020USD ($)	Mar. 31, 2019USD ($)	Dec. 31, 2019USD ($)
Proceeds from convertible secured debenture				$ 125,000
Derivative, fair value				165,000
Amortization of debt discount				150,000
Finance cost				15,000
Unamortization of valuation discount						$ 153,000
Valuation discount				150,000
Amortization of valuation discount				146,000
Remaining unamortization of valuation discount				157,000
Accrued interest to related parties				39,000		202,000
Debt instrument converted interest				29,000
Related Parties [Member]
Accrued interest to related parties				212,000
YA II PN, Ltd. [Member]
Convertible notes payable		$ 275,000	$ 1,500,000
Interest rate		10.00%	8.00%
Debt maturity date		Apr. 30, 2020	Jun. 30, 2020
Conversion price percentage		75.00%	75.00%
Trading days | Integer		10	10
Warrants, term		5 years	5 years
Warrants to purchase number of shares | shares		13,000,000	13,000,000
Warrants, exercise price | $ / shares		$ 0.05	$ 0.05
Warrant expiration date		Dec. 31, 2024	May 31, 2024
Secured convertible debenture				1,900,000		$ 1,750,000
YA II PN, Ltd. [Member] | 2020 Note [Member]
Interest rate	10.00%
Debt maturity date	Aug. 10, 2021
Conversion price percentage	75.00%
Trading days | Integer	10
Warrants, term	5 years
Warrants to purchase number of shares | shares	3,000,000
Warrants, exercise price | $ / shares	$ 0.05
Secured convertible debenture	$ 150,000
Convertible debt, description	The Note bears interest at a rate of 10% per annum (15% on default) and has a maturity date of August 10, 2021.
Debt instrument default interest rate	15.00%
Proceeds from convertible secured debenture	$ 125,000
Closing costs	25,000
Derivative, fair value	$ 140,000
YA II PN, Ltd. [Member] | Extend the Maturity Date [Member]
Convertible notes payable				$ 275,000

Convertible Secured Note Paya_4

Convertible Secured Note Payable to Related Party - Schedule of Secured Notes Payable to Related Party (Details) - YA II PN, Ltd. [Member] - USD ($)	Mar. 31, 2020	Dec. 31, 2019
YA II PN, Ltd.	$ 1,900,000	$ 1,750,000
Less debt discount	(157,000)	(153,000)
Secured note payable, net	$ 1,743,000	$ 1,597,000

Derivative Liability (Details N

Derivative Liability (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Derivative liabilities		$ 1,332,000
Other expenses	$ 942,000
Recognized Derivative Liabilities [Member]
Derivative liabilities	$ 140,000

Derivative Liability - Schedule

Derivative Liability - Schedule of Derivative Liability Weighted Average Assumption (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2020USD ($)$ / shares	Dec. 31, 2019USD ($)$ / shares
Fair Value: Conversion Feature | $	$ 2,414,000	$ 1,332,000
Issued During 2020 [Member]
Fair Value: Conversion Feature | $	$ 140,000
Exercise Price [Member]
Derivative liability, measurement input, price per share	$ 0.008	$ 0.05
Exercise Price [Member] | Issued During 2020 [Member]
Derivative liability, measurement input, price per share	0.02
Stock Price [Member]
Derivative liability, measurement input, price per share	0.01	$ 0.01
Stock Price [Member] | Issued During 2020 [Member]
Derivative liability, measurement input, price per share	$ 0.02
Risk Free Interest Rate [Member]
Derivative liability, measurement input, percentage	140
Risk Free Interest Rate [Member] | Issued During 2020 [Member]
Derivative liability, measurement input, percentage	1.46
Risk Free Interest Rate [Member] | Minimum [Member]
Derivative liability, measurement input, percentage		1.55
Risk Free Interest Rate [Member] | Maximum [Member]
Derivative liability, measurement input, percentage		1.60
Expected Volatility [Member] | Issued During 2020 [Member]
Derivative liability, measurement input, percentage	232
Expected Volatility [Member] | Minimum [Member]
Derivative liability, measurement input, percentage	232	201
Expected Volatility [Member] | Maximum [Member]
Derivative liability, measurement input, percentage	280	203
Expected Life [Member] | Issued During 2020 [Member]
Derivative liability, term	1 year 6 months
Expected Life [Member] | Minimum [Member]
Derivative liability, term	1 year	3 months 29 days
Expected Life [Member] | Maximum [Member]
Derivative liability, term	1 year 6 months	6 months
Expected Dividend Rate [Member]
Derivative liability, measurement input, percentage	0	0
Expected Dividend Rate [Member] | Issued During 2020 [Member]
Derivative liability, measurement input, percentage	0

Shareholders' Equity (Details N

Shareholders' Equity (Details Narrative) - USD ($)	Oct. 31, 2019	Mar. 31, 2020	Mar. 31, 2019
Debt instrument converted value		$ 29,000
Fair value of common stock issued to directors		$ 23,000	$ 63,000
Number of shares granted		2,500,000
Stock issued for compensation, shares		2,500,000
Stock issued for compensation, value		$ 21,000
Stock price		$ 0.03
Risk-free interest rate		1.51%
Expected volatility		1.55%
Expected life		3 years
Number of unvested options
Weighted-average remaining contractual life of options outstanding		2 years 11 months 23 days
Weighted-average remaining contractual life of options exercisable		2 years 11 months 23 days
Intrinsic value of outstanding stock option
Intrinsic value of exercisable stock option
Warrants [Member]
Warrants, term		5 years
Warrants to purchase common stock		3,000,000
Warrants, exercise price		$ 0.05
Warrants weighted average remaining contractual life outstanding and exercisable		4 years 29 days
Intrinsic value of warrants outstanding and exercisable
Director [Member]
Common stock issued to directors, shares		2,166,667
Fair value of common stock issued to directors		$ 23,000
Tiffany Davis [Member]
Fair value of shares, vested	$ 25,000
Number of shares granted		2,500,000
Closing market price		$ 0.01
YA II PN, Ltd. Advisors Global, LP [Member]
Debt instrument converted value		$ 29,000
Debt instrument converted shares		2,287,066
Debt instrument converted price per share		$ 0.0127

Shareholders' Equity - Summary

Shareholders' Equity - Summary of Stock Options Activity (Details)	3 Months Ended
	Mar. 31, 2020$ / sharesshares
Equity [Abstract]
Number of Options outstanding, beginning balance | shares	1,948,300
Number of Options granted | shares	2,500,000
Number of Options exercised | shares
Number of Options expired or forfeited | shares	(15,000)
Number of Options outstanding ending balance | shares	4,433,300
Number of Options exercisable ending balance | shares	4,433,300
Weighted Average Exercise Price outstanding beginning balance | $ / shares	$ 0.35
Weighted Average Exercise Price granted | $ / shares	0.01
Weighted Average Exercise Price exercised | $ / shares
Weighted Average Exercise Price expired or forfeited | $ / shares	(0.69)
Weighted Average Exercise Price outstanding ending balance | $ / shares	0.16
Weighted Average Exercise Price, exercisable ending balance | $ / shares	$ 0.16

Shareholders' Equity - Schedule

Shareholders' Equity - Schedule of Options Outstanding and Exercisable (Details)	3 Months Ended
	Mar. 31, 2020$ / sharesshares
Options outstanding, shares | shares	4,433,300
Options outstanding, life (years)	2 years 11 months 23 days
Options outstanding, weighted average exercise price	$ 0.16
Options exercisable, shares | shares	4,433,300
Options exercisable, weighted average exercise price	$ 0.16
Exercise Price One [Member]
Options outstanding, exercise price per share	$ 0.01
Options outstanding, shares | shares	2,500,000
Options outstanding, life (years)	5 years
Options outstanding, weighted average exercise price	$ 0.01
Options exercisable, shares | shares	2,500,000
Options exercisable, weighted average exercise price	$ 0.01
Exercise Price Two [Member]
Options outstanding, exercise price per share	$ 0.03
Options outstanding, shares | shares	833,300
Options outstanding, life (years)	4 years 7 months 2 days
Options outstanding, weighted average exercise price	$ 0.03
Options exercisable, shares | shares	833,300
Options exercisable, weighted average exercise price	$ 0.03
Exercise Price Three [Member]
Options outstanding, exercise price per share	$ 0.46
Options outstanding, shares | shares	100,000
Options outstanding, life (years)	3 years 8 months 12 days
Options outstanding, weighted average exercise price	$ 0.46
Options exercisable, shares | shares	100,000
Options exercisable, weighted average exercise price	$ 0.46
Exercise Price Four [Member]
Options outstanding, exercise price per share	$ 0.60
Options outstanding, shares | shares	1,000,000
Options outstanding, life (years)	2 years 10 months 10 days
Options outstanding, weighted average exercise price	$ 0.60
Options exercisable, shares | shares	1,000,000
Options exercisable, weighted average exercise price	$ 0.60

Shareholders' Equity - Schedu_2

Shareholders' Equity - Schedule of Stock Warrants Activity (Details)	3 Months Ended
	Mar. 31, 2020$ / sharesshares
Equity [Abstract]
Number of warrants balance, beginning of period | shares	18,283,140
Number of warrants, granted | shares	3,000,000
Number of warrants, exercised | shares
Number of warrants, expired or forfeited | shares
Number of warrants, balance end of period | shares	21,283,140
Number of warrants, exercisable | shares	21,283,140
Weighted Average Exercise Price balance, beginning of period | $ / shares	$ 0.06
Weighted Average Exercise Price, granted | $ / shares	0.05
Weighted Average Exercise Price, exercised | $ / shares
Weighted Average Exercise Price, expired or forfeited | $ / shares
Weighted Average Exercise Price balance, end of period | $ / shares	0.05
Weighted Average Exercise Price, exercisable | $ / shares	$ 0.05

Shareholders' Equity - Schedu_3

Shareholders' Equity - Schedule of Warrants Outstanding and Exercisable (Details)	3 Months Ended
	Mar. 31, 2020$ / sharesshares
Warrants [Member]
Outstanding warrants, shares | shares	21,283,140
Outstanding warrants, life (years)	4 years 29 days
Outstanding warrants weighted average exercise price	$ 0.05
Exercisable warrants, shares | shares	21,283,140
Exercisable warrants, weighted average exercise price	$ 0.05
Warrant One [Member]
Outstanding warrants, exercise price per share	$ 0.01
Outstanding warrants, shares | shares	5,000,000
Outstanding warrants, life (years)	3 years 1 month 9 days
Outstanding warrants weighted average exercise price	$ 0.01
Exercisable warrants, shares | shares	5,000,000
Exercisable warrants, weighted average exercise price	$ 0.01
Warrant Two [Member]
Outstanding warrants, exercise price per share	$ 0.05
Outstanding warrants, shares | shares	16,000,000
Outstanding warrants, life (years)	4 years 1 month 9 days
Outstanding warrants weighted average exercise price	$ 0.05
Exercisable warrants, shares | shares	16,000,000
Exercisable warrants, weighted average exercise price	$ 0.05
Warrant Three [Member]
Outstanding warrants, exercise price per share	$ 1.10
Outstanding warrants, shares | shares	283,140
Outstanding warrants, life (years)	2 years 6 months 21 days
Outstanding warrants weighted average exercise price	$ 1.10
Exercisable warrants, shares | shares	283,140
Exercisable warrants, weighted average exercise price	$ 1.10

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - USD ($)	Sep. 25, 2018	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Minimum consulting amount		$ 195,000	$ 575,000
Research and development expense		25,000	9,000
Technology License Agreement [Member] | Third Party Vendor [Member]
Minimum consulting amount		$ 100,000
Royalty percentage of net sales		7.00%
Royalty expenses		$ 1,429,000
Research and development expense		25,000	$ 0
Amended Agreement [Member]
Total royalty owed under agreement		$ 216,000		$ 191,000
Employment Agreement [Member] | Matthew Geschke [Member]
Plaintiff claims damages, value	$ 335,000

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - Subsequent Event [Member] - USD ($)	Jun. 07, 2020	May 08, 2020
Paycheck Protection Program Loan [Member]
Loan amount		$ 205,000
Loan interest rate		1.00%
Loan payable term		18 months
Economic Injury Disaster Loan [Member]
Loan amount	$ 150,000
Loan interest rate	3.75%
Loan payable term	30 years
Monthly installments payable	$ 731